ACON Aclarion Short-Term Debt to Capital

Aclarion (ACON) is developing an innovative AI system for analyzing MRI scans for back issues, ensuring seamless global deployment via a cloud subscription. The business relies on the US market, which eliminates the impact of sanctions and trade conflicts. This chart illustrates the price action, where the indicator equals 0.00, which, against a backdrop of slow physician adoption and insurance complexities, creates certain liquidity risks.
Summary analytical data breakdowns for aclarion.com (ACON)

This indicator assesses liquidity and financial stability by measuring the ratio of liabilities maturing within one year to equity, allowing the short-term debt-to-equity ratio to determine Aclarion (ACON) dependence on rapid refinancing to support the development of its high-precision spinal MRI analysis platform.